BAKER BROS. ADVISORS LP
Top Portfolio Positions
82 positions ·
$17,340,808,631 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| INCY |
Incyte Corp
Healthcare
|
30,744,412 | $2,893,664,057 | 16.69% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
8,799,053 | $2,613,054,769 | 15.07% | |
| INSM |
INSMED Inc
Healthcare
|
7,421,111 | $1,213,500,070 | 7.00% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
2,141,701 | $1,121,116,222 | 6.47% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
42,896,690 | $954,880,319 | 5.51% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
9,555,357 | $929,258,468 | 5.36% | |
| CELC |
Celcuity Inc.
Healthcare
|
7,915,792 | $903,508,498 | 5.21% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
19,919,186 | $759,319,370 | 4.38% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
8,657,242 | $721,061,686 | 4.16% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
36,391,063 | $689,974,554 | 3.98% |
Portfolio Trend
Holdings in CERS
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,215,187 | 10,008,345 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,617,190 | 10,008,345 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,913,268 | 10,008,345 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,166,220 | 12,883,844 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,898,010 | 19,351,087 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $29,995,102 | 19,477,339 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,890,569 | 19,477,339 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,280,116 | 19,477,339 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,812,170 | 19,477,339 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,071,052 | 19,477,339 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,927,991 | 17,239,501 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $39,526,192 | 16,067,558 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,720,647 | 16,067,558 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $58,646,586 | 16,067,558 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $57,843,208 | 16,067,558 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $84,997,381 | 16,067,558 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $75,285,440 | 13,713,195 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $93,386,857 | 13,713,195 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $83,513,357 | 13,713,195 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $81,044,982 | 13,713,195 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $82,416,301 | 13,713,195 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $94,895,309 | 13,713,195 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $85,844,600 | 13,713,195 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $90,507,087 | 13,713,195 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $63,766,356 | 13,713,195 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||